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A BST R AC T   
 
Aims:  The prognostic value of blood pressure and the association between these parameters and 
cardiovascular conditions have been established in literature. In this study, we aimed to investigate 
the correlation between peripheral blood pressure parameters with degree of coronary collateral 
development (CCD) in stable coronary artery disease (CAD) subjects with established critical artery 
stenosis. 
Methods: A total of 363 patients with stable angina pectoris undergoing coronary arteriography were 
enrolled and divided on the basis of the development of CCD into two groups: group with adequate 
CCD (n=120) and group with inadequate CCD (n=243). Peripheral blood pressure parameters were 
evaluated before coronary arteriography. 
Results: Peripheral diastolic blood pressure (DBP) and mean arterial pressure (MAP) levels were 
significantly higher in the inadequate CCC group (81.5±10.7 vs 77.9±9.9, p=0.02 and 100.6±11.8 vs 
96.6±9.3, p<0.001). In Pearson’s correlation analysis revealed that, Peripheral DBP and MAP levels 
were significantly correlated with Rentrope Collateral Grading (r= 0.26, p<0.003 and r=0.29, 
p<0.001, respectively). ROC curve analysis of MAP and DBP for prediction of inadequate. At the 
cut-off value of > 99,8mmHG, sensitivity and specificity of MAP were 57% and 69%, respectively. 
At the cut-off value of >79,5 mmHg, sensitivity and specificity of DBP were 72% and 42%, 
respectively. 
Conclusion: The present study suggests that peripheral DBP and MAP levels may be associated with 
degree of collateral development in chronic stable CAD. Low peripheral DBP and MAP in the case 
of severe coronary stenosis in stable CAD may be an important stimulus for coronary collateral 
development. 
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pressure. 
                                                                                     Copyright © 2018 experimentalbiomedicalresearch.com                                                                                                                                  
Corresponding Author: Dr. Isa Sincer, 
Abant Izzet Baysal University Hospital,  
Department of Cardiology, Golkoy, 14280,  
Bolu, Turkey 
E mail: isasincer@yahoo.com 
ORCID ID: https://orcid.org/0000-0003-2399-9585   
Received 2018-08-09, Revisions 2018-09-15 
Accepted 2018-09-17  
Publication Date 2018-10-01 
EXPERIMENTAL BIOMEDICAL RESEARCH 
http://www.experimentalbiomedicalresearch.com 
                                                        Mansiroglu et al.  Exp Biomed Res 2018; 1(4):145-153 
   
 
146 
 
Introduction 
The support of coronary collaterals for affected 
myocardial area due to ischemia has long been 
known. Ventricular functions, infarct size and 
aneurysm formation are positively affected by 
well-developed coronary collateral vessels [1-
7] . The presence of factors such as proximal 
stenosis, severity of stenosis, duration of 
angina pectoris, male sex, low heart rate, total 
cholesterol, and triglyceride level have been 
shown in many studies when considering the 
factors affecting the formation of collateral 
circulation [8, 9]. It has been shown that there 
is a direct and independent relationship 
between coronary artery disease and blood 
pressure [10].  
Steady and pulsatile components of blood 
pressure are mean arterial pressure (MAP) and 
pulse pressure (PP) respectively. Peripheral 
vascular resistance and ventricular ejection 
together determine the MAP  [11].  Mean 
arterial pressure and diastolic blood pressure, 
systolic blood pressure and pulse pressure are 
not absolutely reliable in estimating central 
blood pressure values  [12].  
Diastolic arterial pressure remains constant 
from the aorta to the periphery while the 
systolic arterial  pressure and pulse pressure 
increases from the aorta to  the periphery in 
young healthy people [12]. The increase in 
pulse pressure may be physiological (such as 
age, body weight, heart rate, sex) or 
pathological (such as changes in vasomotor 
tone, arterial stiffness) [13]. The distinction 
between the two components of blood pressure 
is clinically relevant because recent findings 
have shown that pulse pressure is more 
sensitive to evaluate  cardiovascular risks than 
DBP, SBP, and MAP [13].  Few studies have 
shown the effect of MAP on cardiovascular 
diseases [14,15].  In the 4 Chicago 
epidemiological studies, Dyer et al. showed 
that the steady component of the blood 
pressure (highly correlated with MAP) is even 
stronger with respect to cardiovascular 
diseases than pulse pressure [16]. MAP gives 
the mean perfusion pressure measurements of 
the systemic circulation. Changes in MAP can 
be explained by the combination of systemic 
vascular resistance (SVR), heart rate and mean 
right atrial pressure (mRAP) interaction. MAP 
autoregulation is the most important feature of 
cardiovascular system. Acute falls in MAP are 
met with systemic arterial vasoconstriction, 
increases in pulse volumes (via 
venocontraction and positive inotropes) and 
sympathetic system effects [12]. Different 
levels of critical blood among the organs may 
be due to different factors such as previous 
hypertension history, vasoactive therapy, and 
age. Although there is no significant low value 
for MAP, the recommended value for organ 
hypoperfusion in septic shock guidelines is 
above 65 mm Hg [17].  On the other hand, 
when MAP is above 85 mmHg, regional 
perfusion and tissue oxygenation do not cause 
a problem [18].  
We would like to investigate the relationship 
between mean arterial pressure [(diastolic 
blood pressure + (systolic blood pressure-
systolic diastolic blood pressure / 3)] and 
diastolic blood pressure and CCD development 
in the present study. 
 
Methods 
Three hundred sixty three (259 males, 104 
females) patients who had undergone coronary 
angiography in our institution between March 
2015 and February 2018 were included to the 
study. Of these patients, clinical, laboratory 
and angiographic data were analyzed. Patients 
who had at least 95% luminal narrowing in at 
least one major epicardial coronary artery were 
included. Age, gender, body weight, 
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comorbidities such as diabetes mellitus and 
hypertension, smoking habit and medication 
on use were obtained from the patient files. 
Laboratory data; serum cholesterol and 
glucose levels, hemogram were also noted. If 
the subjects received antihypertensive drug or 
systolic or diastolic blood pressure of the 
participants were higher than 140mmHg or 90 
mmHg, then they have been considered as 
hypertensive. Current use of antidiabetic 
medication or a fasting glucose level above 
126 mg/dl make the diagnosis of diabetes 
mellitus. Hyperlipidemia was defined as total 
cholesterol higher than 200 mg/dl or 
triglyceride higher than 150 mg/dl. Exclusion 
criteria were as follows: a recent (within 6 
months) history of acute coronary syndrome, 
atrial fibrillation, primary valvular disease, 
decompensated heart failure, previous 
coronary artery stenting or bypass operation, 
congenital heart disease, idiopathic dilated or 
hypertrophic cardiomyopathy, recent history 
of blood transfusion, severe hepatic diseases, 
pregnancy, septicemia, the presence of 
coexistent inflammatory disease (e.g. 
rheumatoid arthritis), thrombocytopenia, renal 
failure and malignancy. The study was 
approved by the Local Ethics Committee of the 
institution.    
Laboratory data 
Peripheral venous blood samples were drawn 
from stable CAD patients who were accepted 
for angiography or during regular follow-up 
checkups. Serum glucose, creatinine, total 
cholesterol, high-density lipoprotein 
cholesterol, and low-density lipoprotein 
cholesterol were measured using an automatic 
biochemical analyzer (Architect C8000, USA). 
Complete blood count was determined using 
simultaneous optical and impedance 
measurements (Cell Dyn 3700; Abbott 
Diagnostics, Lake Forest, Illinois, USA).   
Blood Pressure Measurements 
The conventional peripheral blood pressure 
measurements were obtained with invasive 
blood pressure measurements using a 
sphygmomanometer (Clinical Guard BP-1305 
Blood Pressure Monitor, Hangzhou Sejoy Co 
Ltd, Germany) from right arm. Blood pressure 
(BP) was measured by using a standard 
mercury sphygmomanometer with a cuff size 
adapted to the patient’s arm circumference 
applied to the upper non-dominant arm at heart 
level. The measurements were taken 3 times 
and the average of the last 2 measurements was 
calculated. Brachial pulse pressure definition 
was calculated as brachial systolic and 
diastolic blood pressure difference. For 
practical purposes, an approximation to MAP 
can be obtained by applying the following 
simple equation Mean Arterial Pressure= 
Diastolic Pressure + (1/3× Pulse Pressure ) [19] 
Smoking, drinks with caffeine and alcohol 
consumption were banned for 24 hours prior to 
measurements. 
Coronary angiography evaluation  
Femoral or radial artery access by using 
Seldinger technique were done in coronary 
angiographies. More than 95% of epicardial 
coronary stenosis of cases were included to the 
study.  Rentrop classification was applied to 
determine coronary collateral rating [8]. 
According to this classification; Grade 0 refers 
to lack of filling in collateral vessels, Grade 1 
refers to filling in side branches via collateral 
channels without visualization of the epicardial 
artery, Grade 2 refers to partial filling in the 
epicardial major coronary artery via collateral 
channels, and Grade 3 refers to complete 
filling in the epicardial major coronary artery.  
The coronary angiograms were interpreted by 
three interventional cardiologists who were 
blinded to the clinical, laboratory and 
demographic data of the patients. When more 
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than one vessel met the predefined criteria, the 
CCD with the highest Rentrop grade was used 
for analysis. The patients were classified as 
inadequate CCD (Rentrop grades 0-1) and the 
adequte CCD (Rentrop grades 2-3) groups. 
We also measured the Gensini score of each 
participant from the angiography recordings. 
According to the degree of luminal narrowing 
and its geographic significance, a severity 
index assigned for each coronary stenosis to 
make the Gensini score [20].  
 
Statistical analysis 
Statistical analysis were conducted with SPSS 
software (SPSS 16.0 for Windows, IBM Co, 
Chicago, IL, USA). Distribution of the 
variables in study groups were analyzed by 
Kolmogorov-Smirnov test. Normal distributed 
variables were compared by t test and 
expressed as mean ± standard deviation. 
Variables that without normal distribution 
were compared with Mann Whitney U test and 
expressed as median (interquartile range). Chi-
square test used in comparison of 
nonparametric variables between study 
groups. Diagnostic ability of diastolic blood 
pressure and MAP to detect inadequate CCD 
was evaluated with receiver operating 
characteristic curves (ROC). All results were 
considered statistically significant at the level 
of p < 0.05. 
  
Results 
Of the study population 243 (67%) patients had 
inadequate CCD and 120 (33%) had adequate 
CCD.  Baseline patient demographics, 
including age, sex and clinical risk factors, 
were similar between the groups, except that 
the current smoking rate was mildly lower in 
the inadequate CCD group (30% vs 41%, 
p=0.043). Previous medications were also 
comparable between the two groups (Table 1).  
Table 1. General characteristics of the study 
groups. 
Baseline  
characteristics 
Inadequate 
CCD 
( n= 243) 
Adequate 
CCD 
 (n=120) 
p 
Age (mean ±SD) 
(years)) 
62±10 67±10 0.051 
Body mass index 
(kg/m2) 
27.5±4.1 26.2±4.7 0.465 
Male/female 164/79 95/25 0.021 
Hypertension (%) 151(62%) 78(65%) 0.644 
Smoking 62(29,8%) 43(40,9%) 0.043 
Family history 243(13%) 10(9%) 0.210 
Diabetes mellitus 99(41%) 45(37%) 0.211 
Acetyl salicylate 142(58%) 64(53%) 0.356 
Clopidogrel 28(11%) 15(12%) 0.786 
Statin 41(17%) 24(%20) 0,160 
Calcium channel 
blocker 
50(21 %) 24(25%) 0.078 
ACE inhibitor 63(25%) 25(21%) 0.287 
ARB 60(25%) 25(21%) 0.182 
B-blocker 113(%46) 58(48%) 0.742 
CCD: Coronary collateral development. ACE: 
angiotensin-converting enzyme. ARB: 
angiotensin receptor blocker. SD: standard 
deviation. 
 
Most of the serum biochemistry of the subjects 
in inadequate and adequate CCD groups were 
not statistically different, however, compared 
to inadequate CCD group LDL-cholesterol 
(p=0.02) were significantly higher in adequate 
CCD group (Table 2).  
There was no significant difference between 
the two groups in terms of hemoglobin and 
platelet count. Peripheral DBP and MAP levels 
were significantly higher in the inadequate 
CCD group (81.5±10.7 vs 77.9±9.9 p=0.02 and 
100.6±11.8 vs 96.6±9.3 <.001) (Table 3). In 
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Pearson’s correlation analysis revealed that, 
Peripheral DBP and MAP levels were 
significantly correlated with Rentrope 
Collateral Grading (r= 0.26, p<0.003 and 
r=0.29, p<0.001, respectively)  
 
Table: 2. Laboratory data of the study cohort. 
Parameters  Inadequate  
CCD  (n=243) 
Adequate  
CCD 
(n=120) 
p 
Creatinine  
(mg/dl) 
0.95±0.23 0.95±0.25 0.843 
Fasting plasma 
glucose (mg/dl) 
122±50 125±45 0.067 
LDL-cholesterol 
(mg/dl) 
116±39 120±41 0.020 
HDL-cholesterol 
(mg/dl) 
41±10 42±10 0.904 
Triglyceride  
(mg/dl) 
181 ± 111 172±136 0.061 
Total cholesterol 
(mg/dl) 
184±41 188±48 0.248 
Hemoglobin 
 (gr/dl) 
14±1,8 14±1,5 0.257 
Platelet counts 
(k/mm3) 
239±56 233±60 0.224 
Angiography       
Gensini score 43.3±36.8 66±29 <.001 
 
Table 3. Peripheral blood pressure findings. 
Hemodynamic 
detection 
Inadequate  
CCD (n= 
243) 
Adequate  
CCD   
(n=120) 
p 
Heart rate, beat/min 74±10 76±11 0.157 
Peripheral systolic BP 
(mm Hg) 
138±18 135±12 0.056 
Peripheral diastolic BP 
(mm Hg) 
81.5±10.7 77.9±9.9 0.020 
Pulse pressure 
(mmHg) 
57±14 57±12 0.790 
MAP (mmHg) 100.6±11.8 96.6±9.3 <.001 
BP: Blood pressure. MAP:  Mean arterial pressure. 
 
ROC curve analysis was performed to evaluate 
of MAP and DAP for prediction of inadequate 
CCD.  At the cut-off value of > 99, 8 mmHg, 
sensitivity and specificity of MAP were 57% 
and 69%, respectively. At the cut-off value of 
> 79.5 mmHg, sensitivity and specificity of 
DBP were 72% and 42%, respectively (Figure 
1). 
Figure 1. ROC curve analysis of MAP and DAP 
for prediction of inadequate CDD. 
 
At the cut-off value of > 99,8 mmHg , sensitivity 
and specificity of MAP were 57% and 69%, 
respectively (AUC = 0.614, 95% CI, 0.556-0.673). 
At the cut-off value of >79.5 mmHg, sensitivity 
and specificity of DAP were 72% and 42%, 
respectively (AUC = 0.599, 95% CI, 0.539-0.660). 
AUC: area under the curve, CI: Confidence 
interval. 
 
Discussion 
In our study, we found that peripheral arterial 
diastolic blood pressure and mean arterial 
blood pressure were lower in patients with 
adequate coronary collateral arteries than in 
inadequate CAD. Previous studies have shown 
that coronary collateral circulation reduces 
mortality and reduces infarct size [21]. As you 
know the relationship between SBP or DBP 
and cardiovascular disease is well documented 
[22]. In this line with, high SBP values lead to 
atherosclerosis by inducing stiffness in the 
arterial wall and making changes in the 
vascular structure; low DBP causes weak 
coronary flow reserve and thus poor 
myocardial coronary perfusion [23]. Our study 
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in which we found significant associations 
between coronary collaterals, peripheral MAP 
and diastolic blood pressure, has some 
similarities with the study of Ege et al [24] 
which compared central diastolic blood 
pressure values with collaterals. Central blood 
pressure measurements are not practical in 
daily use, and in this sense, it is important to 
show the relationship between peripheral 
blood pressure values and collaterals [24]. 
While increases in SBP contribute to the 
increase in left ventricular pressure and cause 
increase in oxygen damage; decrease in DBP 
can cause coronary perfusion and oxygenation 
[25]. In the study of Ege et al. [24] the decrease 
in DBP was interpreted as an important 
stimulus for angiogenesis. SBP has a minimal 
effect on coronary perfusion in the presence of 
fix stenosis because most of the coronary 
perfusion is in the diastole. Besides, it 
stimulates arteriogenesis of increased shear 
stress caused by high SBP; the basic stimulus 
for angiogenesis is hypoxia [24]. MAP, which 
is predominantly dependent on cardiac output 
and systemic vascular resistance, has been 
identified as the best correlated predictor of 
body mass index (BMI) and waist 
circumference (WC) in the study of Kurtoglu 
et al. [26]. In some studies we can see patients 
that systolic pressure is normal but diastolic 
pressure is high or diastolic pressure normal 
but systolic pressure is high. MAP may be 
more useful in evaluating such patients [26].  
Sesso and colleagues found that the observed 
MAP in young men was strongly associated 
with increased cardiovascular risk with SBP 
and DBP [22]. In studies related with 
pregnancies, it was determined that MAP, 
which is seen in 1st and 2nd trimester, is a 
stronger predictor of other blood pressure 
parameters in preeclampsia. In clinical 
practice, the importance of predicting the MAP 
calculation during the first antenatal visit has 
been emphasized [27].  
In the study of children with ambulatory 
monitoring, the patients were divided into 
groups with and without the MAP; detection of 
hypertensive individuals increased by 19% if 
MAP was included. This increase is interpreted 
as a risk factor for early diagnosis in systolic / 
diastolic hypertension in children with normal 
or borderline high SBP / DBP [28]. Another 
study in children, Escape Trial, evaluated the 
target blood pressure using the MAP: <50 
percent of children with chronic renal failure 
had a significantly better kidney survival than 
those with 50-95 percentile, and the prognostic 
significance of MAP was noted [29].  
In the meta-analysis performed by Miura and 
his colleagues in the Japanese population [30], 
the risk of stroke and myocardial infarction 
were examined with four blood pressure 
indexes (MAP, PP, SBP, DBP). For stroke and 
myocardial infarction, MAP was identified as 
the strongest predictor of risk with SBP, and 
emphasis was placed on the use of MAP in 
hypertension guidelines for diagnosis and 
treatment [30]. 
Considering the limitations of our study, it is a 
single centered and retrospective study. On the 
other hand, the study only involved patients 
with stable coronary artery disease, more 
studies involving all patient groups are needed 
to generalize the findings to all coronary 
patients. 
As a result, peripheral blood pressure 
measurement is easy and repeatable in daily 
practice. Daily blood pressure measurements 
may become more important in the 
identification and follow-up of high-risk 
patients, especially since it is easier to 
calculate MAP values that provide tissue 
feeding and diastolic blood pressure is more 
important in young patient than in older 
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patients. Therefore, there is a need for a wider 
range of randomized studies in order to scan 
and follow coronary artery disease with simple 
blood pressure arterial measurement. 
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